Stocklytics Platform
Asset logo for symbol NKTX
Nkarta
NKTX49
$2.35arrow_drop_down6.19%-$0.15
Penny Stock
Asset logo for symbol NKTX
NKTX49

$2.35

arrow_drop_down6.19%

Performance History

Chart placeholder
Key Stats
Open$2.49
Prev. Close$2.50
EPS-1.83
DividendNon-Dividend
Next Earnings Date-
Dividend Yield %-
Market Cap$165.83M
PE Ratio-
LOWHIGH
Day Range2.25
2.53
52 Week Range1.32
16.24
Ratios
Revenue-
EBITDA Margin %-
EPS-1.83

Score Breakdown

Welcome to Stocklytics

Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.

Analyst Forecast

Period: Next 12 Months

Analyst Ratings

About Nkarta (NKTX)

Nkarta Inc (NKTX) is a biotechnology company that focuses on developing and commercializing engineered natural killer (NK) cell therapies to treat various types of cancer. The company's lead product candidate, NKX101, is designed to target and kill cancer cells by utilizing the body's own immune system. NKX101 has shown promising results in early-stage clinical trials, demonstrating both safety and efficacy. The company is now advancing NKX101 into later-stage clinical trials, with the goal of obtaining regulatory approval and bringing the therapy to market.
NKTX stock has shown strong performance in recent years, with a significant increase in price. The stock has also gained attention from investors and analysts, with many praising the company's innovative approach to cancer treatment. Nkarta's unique technology, which harnesses the power of NK cells, has the potential to revolutionize the field of oncology and provide new hope for patients. The company's strong financial position and strategic partnerships further support its growth prospects.
Sector
Healthcare
Industry
Biotechnology
CEO
Mr. Paul J. Hastings
Headquarters
South San Francisco
Employees
169
Exchange
NASDAQ
add Nkarta  to watchlist

Keep an eye on Nkarta

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

search
help

What is Nkarta 's (NKTX) price per share?

The current price per share for Nkarta (NKTX) is $2.35. The stock has seen a price change of -$0.15 recently, indicating a -6.2% change. This reflects the stock's recent market performance and investor sentiment.
help

What is the 52-week high and low for Nkarta (NKTX)?

For Nkarta (NKTX), the 52-week high is $16.24, which is 591.06% from the current price. The 52-week low is $1.32, the current price is 78.03% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.
help

Is Nkarta (NKTX) a growth stock?

Nkarta (NKTX) has shown an average price growth of -5.34% over the past three years. It has received a score of 5 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying Nkarta as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.
help

What is Nkarta (NKTX) stock price performance year to date (YTD)?

As of the latest data, Nkarta (NKTX) has a year-to-date price change of -63.11%. Over the past month, the stock has experienced a price change of -9.27%. Over the last three months, the change has been -51.65%. Over the past six months, the figure is -58.04%.
help

Is Nkarta (NKTX) a profitable company?

Nkarta (NKTX) has a net income of -$117.5M, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of 0% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at , although specific revenue growth data is currently not available. Operating income is noted at -$131.65M. Furthermore, the EBITDA is -$118.14M.
help

What is the market capitalization of Nkarta (NKTX)?

Nkarta (NKTX) has a market capitalization of $165.84M. The average daily trading volume is 2.32, indicating the stock's liquidity and investor engagement.

Take Your Investments to a Whole New Level